Aspira Women's Health Files S-1/A Amendment
Ticker: AWHL · Form: S-1/A · Filed: May 1, 2025 · CIK: 926617
| Field | Detail |
|---|---|
| Company | Aspira Women'S Health INC. (AWHL) |
| Form Type | S-1/A |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1/a, amendment
Related Tickers: AWH
TL;DR
Aspira Women's Health (AWH) filed an S-1/A, likely for a stock offering. Watch closely.
AI Summary
Aspira Women's Health Inc. filed an S-1/A amendment on May 1, 2025, related to its public offering. The company, formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc., is based in Austin, TX, and operates in the in vitro & in vivo diagnostic substances sector.
Why It Matters
This filing indicates Aspira Women's Health is actively pursuing capital raising or other significant corporate actions, which could impact its stock price and future operations.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to stock offerings or significant corporate changes, which carry inherent market risks.
Key Numbers
- 20250501 — Filing Date (Indicates the date of the S-1/A amendment filing.)
- 2024-12-31 — Fiscal Year End (Shows the company's fiscal year concludes on December 31st.)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer
- 0000926617 (company) — Central Index Key
- VERMILLION, INC. (company) — Former Company Name
- CIPHERGEN BIOSYSTEMS INC (company) — Former Company Name
- AUSTIN, TX (company) — Business Address City and State
- 512-519-0400 (company) — Business Phone Number
FAQ
What is the primary purpose of this S-1/A filing?
The S-1/A filing is an amendment to a registration statement, typically used for public offerings of securities or significant corporate changes, though the specific details are not provided in this header information.
When was Aspira Women's Health Inc. previously known by other names?
Aspira Women's Health Inc. was formerly known as VERMILLION, INC. (name change effective 20070824) and CIPHERGEN BIOSYSTEMS INC (name change effective 20000316).
What is the company's primary industry classification?
The company is classified under 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' with SIC code [2835].
Where is Aspira Women's Health Inc. located?
The company's business and mailing address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738.
What is the SEC file number associated with this filing?
The SEC file number for this filing is 333-286561.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on May 1, 2025 regarding Aspira Women's Health Inc. (AWHL).